These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 35499524)

  • 1. Heterozygous variants in CTR9, which encodes a major component of the PAF1 complex, are associated with a neurodevelopmental disorder.
    Meuwissen M; Verstraeten A; Ranza E; Iwaszkiewicz J; Bastiaansen M; Mateiu L; Nemegeer M; Meester JAN; Afenjar A; Amaral M; Ballhausen D; Barnett S; Barth M; Asselbergh B; Spaas K; Heeman B; Bassetti J; Blackburn P; Schaer M; Blanc X; Zoete V; Casas K; Courtin T; Doummar D; Guerry F; Keren B; Pappas J; Rabin R; Begtrup A; Shinawi M; Vulto-van Silfhout AT; Kleefstra T; Wagner M; Ziegler A; Schaefer E; Gerard B; De Bie CI; Holwerda SJB; Abbot MA; Antonarakis SE; Loeys B
    Genet Med; 2022 Jul; 24(7):1583-1591. PubMed ID: 35499524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo non-synonymous CTR9 variants are associated with motor delay and macrocephaly: human genetic and zebrafish experimental evidence.
    Suzuki H; Aoki K; Kurosawa K; Imagawa K; Ohto T; Yamada M; Takenouchi T; Kosaki K; Ishitani T
    Hum Mol Genet; 2022 Nov; 31(22):3846-3854. PubMed ID: 35717577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal Structure of the Core Module of the Yeast Paf1 Complex.
    Chen F; Liu B; Zeng J; Guo L; Ge X; Feng W; Li DF; Zhou H; Long J
    J Mol Biol; 2022 Jan; 434(2):167369. PubMed ID: 34852272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ctr9, a Key Component of the Paf1 Complex, Affects Proliferation and Terminal Differentiation in the Developing Drosophila Nervous System.
    Bahrampour S; Thor S
    G3 (Bethesda); 2016 Oct; 6(10):3229-3239. PubMed ID: 27520958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paf1 and Ctr9 subcomplex formation is essential for Paf1 complex assembly and functional regulation.
    Xie Y; Zheng M; Chu X; Chen Y; Xu H; Wang J; Zhou H; Long J
    Nat Commun; 2018 Sep; 9(1):3795. PubMed ID: 30228257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo variants in SP9 cause a novel form of interneuronopathy characterized by intellectual disability, autism spectrum disorder, and epilepsy with variable expressivity.
    Tessarech M; Friocourt G; Marguet F; Lecointre M; Le Mao M; Díaz RM; Mignot C; Keren B; Héron B; De Bie C; Van Gassen K; Loisel D; Delorme B; Syrbe S; Klabunde-Cherwon A; Jamra RA; Wegler M; Callewaert B; Dheedene A; Zidane-Marinnes M; Guichet A; Bris C; Van Bogaert P; Biquard F; Lenaers G; Marcorelles P; Ferec C; Gonzalez B; Procaccio V; Vitobello A; Bonneau D; Laquerriere A; Khiati S; Colin E
    Genet Med; 2024 May; 26(5):101087. PubMed ID: 38288683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De Novo Variants in CNOT1, a Central Component of the CCR4-NOT Complex Involved in Gene Expression and RNA and Protein Stability, Cause Neurodevelopmental Delay.
    Vissers LELM; Kalvakuri S; de Boer E; Geuer S; Oud M; van Outersterp I; Kwint M; Witmond M; Kersten S; Polla DL; Weijers D; Begtrup A; McWalter K; Ruiz A; Gabau E; Morton JEV; Griffith C; Weiss K; Gamble C; Bartley J; Vernon HJ; Brunet K; Ruivenkamp C; Kant SG; Kruszka P; Larson A; Afenjar A; Billette de Villemeur T; Nugent K; ; Raymond FL; Venselaar H; Demurger F; Soler-Alfonso C; Li D; Bhoj E; Hayes I; Hamilton NP; Ahmad A; Fisher R; van den Born M; Willems M; Sorlin A; Delanne J; Moutton S; Christophe P; Mau-Them FT; Vitobello A; Goel H; Massingham L; Phornphutkul C; Schwab J; Keren B; Charles P; Vreeburg M; De Simone L; Hoganson G; Iascone M; Milani D; Evenepoel L; Revencu N; Ward DI; Burns K; Krantz I; Raible SE; Murrell JR; Wood K; Cho MT; van Bokhoven H; Muenke M; Kleefstra T; Bodmer R; de Brouwer APM
    Am J Hum Genet; 2020 Jul; 107(1):164-172. PubMed ID: 32553196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BAZ2B haploinsufficiency as a cause of developmental delay, intellectual disability, and autism spectrum disorder.
    Scott TM; Guo H; Eichler EE; Rosenfeld JA; Pang K; Liu Z; Lalani S; Bi W; Yang Y; Bacino CA; Streff H; Lewis AM; Koenig MK; Thiffault I; Bellomo A; Everman DB; Jones JR; Stevenson RE; Bernier R; Gilissen C; Pfundt R; Hiatt SM; Cooper GM; Holder JL; Scott DA
    Hum Mutat; 2020 May; 41(5):921-925. PubMed ID: 31999386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De novo missense variants in ZBTB47 are associated with developmental delays, hypotonia, seizures, gait abnormalities, and variable movement abnormalities.
    Ward SK; Wadley A; Tsai CA; Benke PJ; Emrick L; Fisher K; Houck KM; Dai H; ; Guillen Sacoto MJ; Craigen W; Glaser K; Murdock DR; Rohena L; Diderich KEM; Bruggenwirth HT; Lee B; Bacino C; Burrage LC; Rosenfeld JA
    Am J Med Genet A; 2024 Jan; 194(1):17-30. PubMed ID: 37743782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Truncating Variants in NAA15 Are Associated with Variable Levels of Intellectual Disability, Autism Spectrum Disorder, and Congenital Anomalies.
    Cheng H; Dharmadhikari AV; Varland S; Ma N; Domingo D; Kleyner R; Rope AF; Yoon M; Stray-Pedersen A; Posey JE; Crews SR; Eldomery MK; Akdemir ZC; Lewis AM; Sutton VR; Rosenfeld JA; Conboy E; Agre K; Xia F; Walkiewicz M; Longoni M; High FA; van Slegtenhorst MA; Mancini GMS; Finnila CR; van Haeringen A; den Hollander N; Ruivenkamp C; Naidu S; Mahida S; Palmer EE; Murray L; Lim D; Jayakar P; Parker MJ; Giusto S; Stracuzzi E; Romano C; Beighley JS; Bernier RA; Küry S; Nizon M; Corbett MA; Shaw M; Gardner A; Barnett C; Armstrong R; Kassahn KS; Van Dijck A; Vandeweyer G; Kleefstra T; Schieving J; Jongmans MJ; de Vries BBA; Pfundt R; Kerr B; Rojas SK; Boycott KM; Person R; Willaert R; Eichler EE; Kooy RF; Yang Y; Wu JC; Lupski JR; Arnesen T; Cooper GM; Chung WK; Gecz J; Stessman HAF; Meng L; Lyon GJ
    Am J Hum Genet; 2018 May; 102(5):985-994. PubMed ID: 29656860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole exome sequencing reveals de novo pathogenic variants in KAT6A as a cause of a neurodevelopmental disorder.
    Millan F; Cho MT; Retterer K; Monaghan KG; Bai R; Vitazka P; Everman DB; Smith B; Angle B; Roberts V; Immken L; Nagakura H; DiFazio M; Sherr E; Haverfield E; Friedman B; Telegrafi A; Juusola J; Chung WK; Bale S
    Am J Med Genet A; 2016 Jul; 170(7):1791-8. PubMed ID: 27133397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism.
    Kim HG; Rosenfeld JA; Scott DA; Bénédicte G; Labonne JD; Brown J; McGuire M; Mahida S; Naidu S; Gutierrez J; Lesca G; des Portes V; Bruel AL; Sorlin A; Xia F; Capri Y; Muller E; McKnight D; Torti E; Rüschendorf F; Hummel O; Islam Z; Kolatkar PR; Layman LC; Ryu D; Kong IK; Madan-Khetarpal S; Kim CH
    Mol Autism; 2019; 10():35. PubMed ID: 31649809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical and molecular spectrum of QRICH1 associated neurodevelopmental disorder.
    Kumble S; Levy AM; Punetha J; Gao H; Ah Mew N; Anyane-Yeboa K; Benke PJ; Berger SM; Bjerglund L; Campos-Xavier B; Ciliberto M; Cohen JS; Comi AM; Curry C; Damaj L; Denommé-Pichon AS; Emrick L; Faivre L; Fasano MB; Fiévet A; Finkel RS; García-Miñaúr S; Gerard A; Gomez-Puertas P; Guillen Sacoto MJ; Hoffman TL; Howard L; Iglesias AD; Izumi K; Larson A; Leiber A; Lozano R; Marcos-Alcalde I; Mintz CS; Mullegama SV; Møller RS; Odent S; Oppermann H; Ostergaard E; Pacio-Míguez M; Palomares-Bralo M; Parikh S; Paulson AM; Platzer K; Posey JE; Potocki L; Revah-Politi A; Rio M; Ritter AL; Robinson S; Rosenfeld JA; Santos-Simarro F; Sousa SB; ; Wéber M; Xie Y; Chung WK; Brown NJ; Tümer Z
    Hum Mutat; 2022 Feb; 43(2):266-282. PubMed ID: 34859529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CTCF variants in 39 individuals with a variable neurodevelopmental disorder broaden the mutational and clinical spectrum.
    Konrad EDH; Nardini N; Caliebe A; Nagel I; Young D; Horvath G; Santoro SL; Shuss C; Ziegler A; Bonneau D; Kempers M; Pfundt R; Legius E; Bouman A; Stuurman KE; Õunap K; Pajusalu S; Wojcik MH; Vasileiou G; Le Guyader G; Schnelle HM; Berland S; Zonneveld-Huijssoon E; Kersten S; Gupta A; Blackburn PR; Ellingson MS; Ferber MJ; Dhamija R; Klee EW; McEntagart M; Lichtenbelt KD; Kenney A; Vergano SA; Abou Jamra R; Platzer K; Ella Pierpont M; Khattar D; Hopkin RJ; Martin RJ; Jongmans MCJ; Chang VY; Martinez-Agosto JA; Kuismin O; Kurki MI; Pietiläinen O; Palotie A; Maarup TJ; Johnson DS; Venborg Pedersen K; Laulund LW; Lynch SA; Blyth M; Prescott K; Canham N; Ibitoye R; Brilstra EH; Shinawi M; Fassi E; ; Sticht H; Gregor A; Van Esch H; Zweier C
    Genet Med; 2019 Dec; 21(12):2723-2733. PubMed ID: 31239556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. hCTR9, a component of Paf1 complex, participates in the transcription of interleukin 6-responsive genes through regulation of STAT3-DNA interactions.
    Youn MY; Yoo HS; Kim MJ; Hwang SY; Choi Y; Desiderio SV; Yoo JY
    J Biol Chem; 2007 Nov; 282(48):34727-34. PubMed ID: 17911113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel CIC variants identified in individuals with neurodevelopmental phenotypes.
    Sharma S; Hourigan B; Patel Z; Rosenfeld JA; Chan KM; Wangler MF; Yi JS; Lehman A; ; Horvath G; Cloos PA; Tan Q
    Hum Mutat; 2022 Jul; 43(7):889-899. PubMed ID: 35165976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variants in PRKAR1B cause a neurodevelopmental disorder with autism spectrum disorder, apraxia, and insensitivity to pain.
    Marbach F; Stoyanov G; Erger F; Stratakis CA; Settas N; London E; Rosenfeld JA; Torti E; Haldeman-Englert C; Sklirou E; Kessler E; Ceulemans S; Nelson SF; Martinez-Agosto JA; Palmer CGS; Signer RH; ; Andrews MV; Grange DK; Willaert R; Person R; Telegrafi A; Sievers A; Laugsch M; Theiß S; Cheng Y; Lichtarge O; Katsonis P; Stocco A; Schaaf CP
    Genet Med; 2021 Aug; 23(8):1465-1473. PubMed ID: 33833410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rare and de novo duplications containing TCF20 are associated with a neurodevelopmental disorder.
    Lévy J; Cogan G; Maruani A; Maillard A; Dupont C; Drunat S; Rachid M; Atzori P; Delorme R; Jeyarajah S; Isidor B; Pichon O; Moradkhani K; Verloes A; Tabet AC
    Clin Genet; 2022 Mar; 101(3):364-370. PubMed ID: 34904221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo heterozygous missense and loss-of-function variants in CDC42BPB are associated with a neurodevelopmental phenotype.
    Chilton I; Okur V; Vitiello G; Selicorni A; Mariani M; Goldenberg A; Husson T; Campion D; Lichtenbelt KD; van Gassen K; Steinraths M; Rice J; Roeder ER; Littlejohn RO; Srour M; Sebire G; Accogli A; Héron D; Heide S; Nava C; Depienne C; Larson A; Niyazov D; Azage M; Hoganson G; Burton J; Rush ET; Jenkins JL; Saunders CJ; Thiffault I; Alaimo JT; Fleischer J; Groepper D; Gripp KW; Chung WK
    Am J Med Genet A; 2020 May; 182(5):962-973. PubMed ID: 32031333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De Novo Variants in the ATPase Module of MORC2 Cause a Neurodevelopmental Disorder with Growth Retardation and Variable Craniofacial Dysmorphism.
    Guillen Sacoto MJ; Tchasovnikarova IA; Torti E; Forster C; Andrew EH; Anselm I; Baranano KW; Briere LC; Cohen JS; Craigen WJ; Cytrynbaum C; Ekhilevitch N; Elrick MJ; Fatemi A; Fraser JL; Gallagher RC; Guerin A; Haynes D; High FA; Inglese CN; Kiss C; Koenig MK; Krier J; Lindstrom K; Marble M; Meddaugh H; Moran ES; Morel CF; Mu W; Muller EA; Nance J; Natowicz MR; Numis AL; Ostrem B; Pappas J; Stafstrom CE; Streff H; Sweetser DA; Szybowska M; ; Walker MA; Wang W; Weiss K; Weksberg R; Wheeler PG; Yoon G; Kingston RE; Juusola J
    Am J Hum Genet; 2020 Aug; 107(2):352-363. PubMed ID: 32693025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.